# Biogen Inc. (BIIB): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Biogen Inc. (BIIB) is 78/100, ranked against 24,000+ stocks in 35 markets (Quality 56, Value 49, Momentum 69, each scored against its sector).

- StockRank: 78/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 56, Value 49, Momentum 69: each a 0-100 percentile within Healthcare.
- Position: #5,881 overall, #643 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - General.
- Last close: 250.69 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 240K.

Source: https://moatmap.ai/stock/BIIB
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker